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Abstract
The DREAM complex plays an important role in regulation of gene expression during the cell cycle. We have previously
shown that the DREAM subunit LIN9 is required for early embryonic development and for the maintenance of the inner cell
mass in vitro. In this study we examined the effect of knocking down LIN9 on ESCs. We demonstrate that depletion of LIN9
alters the cell cycle distribution of ESCs and results in an accumulation of cells in G2 and M and in an increase of polyploid
cells. Genome-wide expression studies showed that the depletion of LIN9 results in downregulation of mitotic genes and in
upregulation of differentiation-specific genes. ChIP-on chip experiments showed that mitotic genes are direct targets of
LIN9 while lineage specific markers are regulated indirectly. Importantly, depletion of LIN9 does not alter the expression of
pluripotency markers SOX2, OCT4 and Nanog and LIN9 depleted ESCs retain alkaline phosphatase activity. We conclude that
LIN9 is essential for proliferation and genome stability of ESCs by activating genes with important functions in mitosis and
cytokinesis.
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Introduction
Pluripotent embryonic stem cells (ESCs) are derived from the
inner cell mass (ICM) of the pre-implantation embryo. ESCs have
the unique ability to self-renew while retaining the ability to
differentiate into any cell type of the adult animal. Self-renewal
and pluripotency of ESCs is maintained by a set of pluripotency
transcription factors such as SOX2, OCT4 and Nanog and by
polycomb group complexes that maintain the undifferentiated
state of ESCs through the repression of developmental genes [1].
Inactivation of pluripotency factors or polycomb proteins leads to
loss of pluripotent cells and aberrant differentiation. Embryonic
stem cells are also characterized by an unusual cell cycle. ESCs
proliferate much faster than differentiated cells due to very short
G1 and G2 phases [2], [3]. The abnormal cell cycle structure of
ESCs is intimately linked to the unique features of ESCs.
However, the relationship between cell cycle regulation and
ESC pluripotency is incompletely understood. For example, while
it has been suggested that the short G1 phase of ESCs inhibits their
differentiation and preserves pluripotency, a recent study showed
that a short G1 phase is not sufficient to prevent differentiation of
ESCs [4].
LIN9 is a subunit of the evolutionary conserved DREAM
complex that was first described in Drosophila and was shown to
function as a repressor of cell cycle regulated genes [5], [6]. In
human cells DREAM consists of a five-protein core module and
associated proteins [7], [8]. DREAM undergoes a cell cycle
dependent switch of subunits. Specifically, in quiescent cells the
DREAM core module binds to the E2F4 transcription factor and
to the p130 retinoblastoma protein to establish a repressor
complex. In the S-phase, binding to E2F4/p130 is lost and
DREAM now associates with the transcription factor B-MYB,
yielding a transcriptional activator complex. DREAM-B-MYB has
a crucial role in cell cycle progression. Specifically, it is required
for normal progression through mitosis and cytokinesis because it
activates a set of key mitotic genes such as Cyclin B, BUB1 and
Aurora A [9], [7], [8], [10]. DREAM is also essential during early
embryonic development, since mice lacking the DREAM subunit
LIN9 or B-MYB die shortly after implantation because the inner
cells mass (ICM) is not maintained after implantation [11], [12]. B-
MYB is also required in ESCs for proper expression of critical cell
cycle regulators such as Cyclin B1 and PLK1 and pluripotency
genes such as OCT4 and SOX2 [13], [14]. Thus, B-MYB is
important not only for cell cycle progression but also for the
pluripotent state of ESCs and both functions may contribute to the
early lethal phenotype of B-MYB mutant embryos. Given that
LIN9 and B-MYB are both subunits of the DREAM complex
together with the finding that they are essential at a similar stage
during embryonic development, it is possible that DREAM also
plays important roles in ESC proliferation and pluripotency.
However the role of the DREAM core complex in ESCs has not
been investigated.
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To explore the function of DREAM in ESCs, we depleted the
conserved core-subunit LIN9 by RNAi and found that it is
required for normal cell cycle progression and genome stability.
Microarray and ChIP-on-chip experiments showed that mitotic
genes are direct targets of LIN9 in ESCs. Although depletion of
LIN9 also resulted in upregulation of some lineage specific genes,
the cells remained undifferentiated and the expression of key stem
cell regulators was maintained. Together our results indicate a role
for LIN9 in gene expression at mitosis in ESCs.
Results
Lin9 Expression in Mouse Pre-implantation Embryos
We have previously shown that deletion of Lin9 in mice leads to
early embryonic lethality at the peri-implantation stage [11]. LIN9
is also required for maintenance of the inner cell mass (ICM)
in vitro in pre-implantation embryos [11]. To further analyze the
reason for embryonic lethality, we investigated the expression of
Lin9 mRNA in 3.5 and 4.5 dpc blastocysts by in situ hybridization.
Oct4, an epiblast marker, was used as a control [15]. Lin9 mRNA
was detected in the ICM of 3.5 and 4.5 embryos (Fig. 1A). In
addition it could also be detected in the trophoectoderm of 4.5
embryos. Oct4 showed ICM specific expression, as expected
(Fig. 1A). The expression of Lin9 in pre-implantation embryos is
consistent with its role in early development.
LIN9 is a Component of the DREAM Complex in ESCs
We next investigated the expression of LIN9 in ESCs, which are
derived from the inner cell mass of pre-implantation blastocysts
[16]. LIN9 was immunoprecipitated from nuclear lysates. By
immunoblotting with an antibody directed at LIN9, a single band
was detected at the expected size, confirming that the LIN9
protein is expressed in ESCs (Fig. 1B). B-MYB, LIN54 and LIN37
co-precipitated with LIN9, indicating that LIN9 is part of the
DREAM complex in ESCs (Fig. 1B). Interactions with DREAM
subunits were specific, because no signal was observed with
immunprecipitations with nonspecific IgG. The LIN52 subunit of
DREAM and RbAp48 could not be analyzed because of the lack
of suitable antibodies directed at the mouse proteins. p130 was not
expressed in ESCs and therefore no interaction with LIN9 was
detected (Fig. 1B). Although p107 is expressed in growing ESCs, it
did not co-precipitate with LIN9. Thus, LIN9 associates with the
core components of DREAM and with B-MYB in ESCs but not
with pocket proteins. In summary, LIN9 is expressed in pre-
implantation embryos and in ESCs and it could play a role in cell
cycle regulation or differentiation of ESCs.
Impaired Embryoid Body Formation Upon Depletion of
LIN9 in ESCs
Because LIN9 is required for early embryonic development, we
next wanted to analyze the developmental capacity of LIN9
depleted ESCs. The formation of embryoid bodies is an accepted
in vitro model of differentiation and development [17]. Embryoid
body formation can be triggered by culturing the ESCs under
nonadherent conditions in the absence of leukemia inhibitory
factor (LIF). To investigate the role of LIN9 in embryoid body
formation, we transfected ESCs with a vector encoding a
puromycin resistance gene and a LIN9-specific shRNA. After 3
Figure 1. Expression of Lin9 in pre-implantation embryos and ESCs. (A) Expression of Lin9 mRNA in 3.5 and 4.5 dpc blastocysts was analyzed
by in situ hybridization with a DIG-labeled Lin9 probe. As a control, Oct4 mRNA was analyzed. (B) Nuclear lysates from ESCs were immunoprecipitated
with a LIN9 antibody or with nonspecific IgG as a control. Co-precipitated proteins were detected with the antibodies indicated. Input (5%) was also
loaded on the gel for comparison.
doi:10.1371/journal.pone.0062882.g001
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days of puromycin selection, the efficiency of LIN9 depletion was
tested at the mRNA and protein level. A significant decrease in
LIN9 mRNA and protein was detected by RT-qPCR and
immunoblotting in cells expressing the LIN9-specific shRNA
compared to a control shRNA (Fig. 2A,B ). Next, equal number of
control cells and LIN9 depleted cells were seeded in hanging drops
for embryoid body formation (Fig. 2C). Two days later, embryoid
bodies were harvested and plated onto dishes coated with poly-
hema in the absence of LIF. Control transfected ESCs increased in
size during the course of the experiment (Fig. 2D, Supplemental
Fig. S1). In contrast, embryoid bodies in LIN9 depleted cells were
much smaller compared to controls and did not significantly
increase in size when cultured for up to 6 days (Fig. 2D).
Depletion of LIN9 in ESCs by RNAi Results in
Accumulation of Cells with 4n DNA Content and of
Polyploid Cells
To investigate whether the reduced size of embryoid bodies is
due to changes in the differentiation status of the ESCs, we
performed alkaline phosphatase (AP) staining. AP activity can be
detected only in undifferentiated ESCs and is rapidly lost when the
cells differentiate. Therefore the AP assay can be used to assess the
self-renewal capacity of ESCs. AP staining was performed with
cells transfected with the LIN9 specific shRNA or with a control
shRNA. LIN9 depleted cells maintained alkaline phosphatase
activity indicating that the cells remain undifferentiated (Fig. 3A).
However, LIN9-deficient colonies were smaller and contained
fewer cells than control colonies. Pluripotent ESCs are maintained
in an undifferentiated state by a set of key transcription factors
including Oct4 and Sox2. The expression levels of Oct4 and Sox2
did not differ between control cells and LIN9-depleted cells,
indicating that LIN9 is not required for maintaining the expression
of these pluripotency genes. These data are consistent with the
maintenance of AP activity in LIN9 depleted cells (Fig. 3B).
The reduction in cell number could be due to changes in cell
cycle progression. To investigate whether depletion of LIN9 leads
to changes in cell cycle progression, we compared the cell cycle
profiles of LIN9-depleted cells with that of control cells by flow
cytometry. After depletion of LIN9 for 3 days, a significant
decrease in the proportion of cells in G1 and S-phase and an
increase in the proportion of cells in G2/M was observed (Fig. 3C).
Of note, polyploid cells with .4n DNA content were also
significantly increased from 2.8% in control cells to 15.6% in LIN9
depleted cells. These results indicate that LIN9 is required for
normal cell cycle progression and for genome stability of ESCs.
Knockdown of LIN9 Results in the Reduction of Mitotic
Gene Expression and in Induction of Differentiation
Markers
To identify changes in gene expression that could be responsible
for altered cell cycle progression after depletion of LIN9 in ESCs,
we performed gene expression profiling using microarray analysis.
RNA was isolated from control cells and from cells transfected
with the LIN9 specific shRNA plasmid and subjected to Agilent
DNA microarrays monitoring more than 39,000 transcripts. In
total 581 genes showed .1.5 fold expression changes between
control cells and LIN9 depleted cells (Fig. 4A, Supplemental Table
S1). Of these, 348 genes were upregulated and 233 genes
downregulated in LIN9 depleted cells compared to control cells
(Fig. 4A).
To gain insights into the deregulated processes in ESCs after
depletion of LIN9 we performed a gene ontology analysis (GO).
This analysis indicated genes associated with cell cycle, mitosis and
chromosome segregation were strongly overrepresented among
the downregulated genes, consistent with the cell cycle phenotype
of LIN9 depleted ESCs (Fig. 4B, Supplemental Table S2). GO
terms overrepresented in the upregulated genes include lung
development, angiogenesis, and neuronal development. This
indicates that LIN9 directly or indirectly represses genes associated
with differentiation and development (Fig. 4C, Supplemental
Table S3).
We validated the regulation of a subset genes discovered in the
microarray by quantitative real time PCR (RT-qPCR) (Fig. 5A,C).
These experiments confirmed downregulation of mitotic genes
such as Aurora A, Cyclin B1 and Nusap1 (Fig. 5A). Decreased
expression of mitotic Cyclin B was also confirmed on protein level
by immunoblotting (Fig 5B). Upregulation of differentiation
markers upon depletion of LIN9 including Id4, Vax2, Neurod1
and Stmn3 could also be confirmed (Fig. 5C).
Genome Wide Binding of LIN9 to Promoters in ESCs
To determine which genes are direct transcriptional targets of
LIN9 in ESCs, we performed a genome-wide ChIP-on-chip
analysis of promoters bound by LIN9 in ESCs. To facilitate
precipitation of LIN9 from ESCs, we first generated an ESC line
stably expressing a tagged version of LIN9 with a recognition
sequence for the biotinylating enzyme BirA, which mediates in vivo
biotinylation of the tagged protein. A construct encoding for LIN9
fused to a biotin ligase recognition peptide (Bio-LIN9) was
introduced into ESCs expressing BirA ligase [18] (Fig. 6A). Cells
were selected with neomycin for 5 days. Single clones that express
the LIN9 protein at similar level to endogenous LIN9 were
identified by immunoblotting (data not shown and Fig. 6B). Pull-
down assays using nuclear extract with streptavidin-coupled
magnetic beads resulted in efficient and specific precipitation of
LIN9 indicating that the tagged protein is efficiently biotinylated
in vivo (Fig. 6C). Importantly, immunoblot analysis showed that B-
MYB, LIN54 and LIN37 were present in streptavidin pulldown
assays from Bio-LIN9 cells (Fig. 6D). This indicates that exogenous
Bio-LIN9 is efficiently incorporated into the endogenous DREAM
complex in ESCs.
To identify the promoters that were bound by LIN9 in ESCs,
we next performed ChIP-on-chip experiments. Chromatin from
cells expressing biotin-tagged LIN9 was precipitated with
streptavidin coupled magnetic beads, amplified, labeled and
hybridized to a microarray that contains oligonucleotide probes
covering the region 22 to +0.5 kb relative to the transcriptional
start sites of 19,489 annotated mouse genes. Overall, LIN9 bound
to 1411 (7.2%) of the promoter regions analyzed (Supplemental
S4). Functional annotation analysis based on GO terms revealed a
significant enrichment on promoters of genes that are involved in
regulation of mitosis, transcription, translation and mRNA
processing (Fig. 7A and Supplemental Table S5).
By combining the ChIP-on-chip data with the microarray data,
we determined which of the genes that change in expression upon
depletion of LIN9 are directly regulated by LIN9.
Overall, only 59 of the 581 genes that that showed significant
changes in gene expression had LIN9 bound in their promoter
region (Table 1). 33 of the directly regulated genes were
downregulated and 26 upregulated. Most significantly, LIN9
bound to the promoter regions of 15 of the 30 downregulated
mitotic genes identified in the transcriptional profiling, indicating
that the many of these genes are direct targets of LIN9 (Fig. 7B).
Conventional chromatin immunoprecipitation (ChIP) experiments
independently confirmed binding of LIN9 to the promoters of the
mitotic genes Aspm, Aurora A, Hmmr and Kif20a in ESCs, while
no association with the Sox2 promoter was detected (Fig. 7C). In
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contrast to the downregulated genes, the upregulated genes bound
by LIN9 in ESCs cannot be assigned to distinct biological
processes or pathways.
As shown above, the depletion of LIN9 in ESCs resulted in
upregulation of several differentiation specific genes such as Id4,
NeuroD1, Vax2, Tbx4 and Socs2. However, binding of LIN9 to
the promoters of these genes was not detected in the ChIP-on-chip
analysis, suggesting that LIN9 indirectly regulates these genes.
B-MYB, which is also a part of the DREAM activating
complex, has recently been shown to bind to the promoters of
pluripotency genes Sox2, Nanog and Pou5f1 in ESCs [13], [14].
However, no binding of LIN9 to the promoters of these genes as
well as to other pluripotency genes such as Klf4 was detected by
ChIP-on-chip (Figure 7C, Supplemental Table S4). This result is
consistent with unchanged expression of these genes upon
depletion of LIN9 (see Fig. 3B).
In conclusion the ChIP-on-chip analysis demonstrated that
mitotic genes are directly regulated by LIN9. In contrast, the
expression of differentiation genes appears to be indirectly
regulated by LIN9. Furthermore LIN9 does not bind to or
regulate the expression of pluripotency genes.
Figure 2. Impaired embryoid body formation after depletion of LIN9 in ESCs. ESCs were transfected with a plasmid encoding a LIN9
specific shRNA. LIN9 mRNA (A) and protein levels (B) were compared with the levels in control-transfected cells by RT-qPCR and immunoblotting. (C)
Embryoid body formation: Outline of the experiment. Equal numbers of LIN9 depleted ESCs or control cells were placed in hanging drops on lids of
cell culture dishes. After two days, embryoid bodies were harvested and grown in suspension in the absence of LIF for up to 6 days. (D) Embryoid
bodies formed in control cells and LIN9-depleted cells. Scale bar: 100 mM. See Figure S1 for additional examples of embryoid bodies formed in control
cell and LIN9 depleted cells from an independent experiment.
doi:10.1371/journal.pone.0062882.g002
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Discussion
We describe the first genome-wide analysis of genes regulated
by the DREAM-subunit LIN9 in murine ESCs by using a
combination of RNAi mediated depletion of LIN9 and microarray
experiments. We found that LIN9 is required for the activation of
key mitotic genes such as Plk1, Aurora A and Cyclin B in ESCs.
Genome wide ChIP-on-chip experiments showed that mitotic
genes are direct targets of LIN9. The consequences of depletion of
LIN9 in ESCs are impaired proliferation and drastically reduced
embryoid body formation, an in vitro model of differentiation.
Furthermore, depletion of LIN9 resulted in accumulation of cells
in G2/M and in polyploidy. These data indicate that LIN9 is
required for proper maintenance of genome stability in ESCs
because it functions as a master regulator of mitotic gene
expression.
The role of LIN9 in regulating ESC proliferation is consistent
with the results from our in vivo studies shown that deletion of
LIN9 in mice leads to early embryonic lethality [11]. Lin9
knockout embryos develop to the blastocyst stage and implant but
die shortly thereafter because cell types that are derived from the
inner cells mass (ICM) are not maintained after implantation [11].
In addition, in in vitro cultures of Lin9 mutant blastocysts the ICM
is not maintained. The experiments described here suggest that the
embryonic lethality of Lin92/2 mice is due to defects in ICM
proliferation and due to genome instability because of a global
reduction in mitotic gene expression. After implantation of the
mouse embryo, epiblast cells form a single cell layer of columnar
epithelium. Before gastrulation the epiblast undergoes a rapid cell
proliferation, with cell cycles as short as 5 hours, to expand the
pluripotent cell population from 25 cells at 4.5 dpc to ,660 cells
by 6.5 dpc [19]. It is likely that a failure of epiblast proliferation
Figure 3. Cell cycle arrest in G2/M after depletion of LIN9. (A) Alkaline-phosphatase (AP) staining of control cells and LIN9 depleted cells. Scale
bar: 200 mM (B) Expression of pluripotency markers Oct4 and Sox2 was analyzed in control-depleted cells and LIN9 depleted cells by RT-qPCR. (C) The
cell cycle profile of LIN9 depleted ESCs and of control cells was analyzed by flow cytometry.
doi:10.1371/journal.pone.0062882.g003
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Figure 4. Gene expression changes after depletion of LIN9 in ESCs. (A) Number of up- and downregulated genes in LIN9 depleted cells
identified by microarray analysis. For a list of regulated genes see Supplemental Table S1 (B) & (C) GO analysis was applied to differentially expressed
genes. Listed are the top fifteen overrepresented GO terms according to the p-value. For complete lists of GO terms with a p-value of less than 0.05
see Supplemental Table S2 and S3.
doi:10.1371/journal.pone.0062882.g004
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contributes to the lethality of Lin9 knockout embryos. Consistent
with this notion several of the mitotic targets of LIN9 are also
essential during early murine development. For example, inacti-
vation of LIN9 targets Cyclin B1 or Plk1 results in embryonic
lethality [20],[21]. In addition, LIN9 target genes Bub3, Cenpa,
Cenpe and Incenp that function in mitotic checkpoint and
kinetochore function, are also required for cell viability at the peri-
implantation stage [22],[23],[24],[25]. This suggests that abnor-
mal mitotic progression due to downregulation of these genes
contributes to the lethal phenotype of Lin9 embryos.
LIN9 depletion in ESCs not only resulted in downregulation of
mitotic genes but also in upregulation of lineage-specific differen-
tiation markers such as NeuroD1, Flk1, Afp or Gata6. No binding
of LIN9 to the promoters of these and other differentiation genes
was observed, indicating that these differentiation-specific genes
are upregulated indirectly. It is possible that their activation in the
absence of LIN9 is mediated by activating E2F proteins. However,
except for one gene (Pdgfra) they have not been described as E2F-
targets before [26]. Thus, their upregulation could be an indirect
consequence of changes in cell cycle progression. Despite
upregulation of differentiation genes, AP staining was maintained
and expression of pluripotency markers such as Oct4 and Sox2
was not decreased after depletion of LIN9. This indicates that the
cells are undifferentiated and that they maintain their self-renewal
capacity and pluripotency. Thus, although depletion of LIN9
results in a shift towards expression of markers of the differentiated
state, it does not induce widespread differentiation and it does not
result in loss of pluripotency. During lineage diversification, the
upregulation of lineage specific genes is normally correlated with a
downregulation of self-renewal genes. However, when LIN9 is
depleted this process is disrupted and although lineage specific
genes are induced, the expression of pluripotency genes is
maintained.
The relationship between cell cycle regulation of ESCs and self-
renewal is not well understood. Embryonic stem cells have a very
short G1 phase and a high proliferation rate, which may be
required to maintain their pluripotent state [27–31]. Specifically, it
has been proposed that the short G1 phase minimizes their
sensitivity to differentiation signals and thus helps to prevent ESCs
from inappropriate differentiation. Thus, an extended G1 phase
could make cells more susceptible to differentiation signals and
may be a prerequisite of ESC differentiation. However, in a recent
study it was shown that simply prolonging the G1 phase of mouse
ESCs is not sufficient to induce their differentiation [4]. Whether
normal progression through G2 and mitosis is functionally linked
to pluripotency has not been investigated. We find that reduced
proliferation due to a decreased expression of mitotic genes after
depletion of LIN9 is not sufficient to induce differentiation. This
supports the notion that simply lengthening the ESC cell cycle
does not automatically promote ESC differentiation.
Our finding that LIN9 is required for expression of mitotic
genes in ESCs is in agreement with the known function of LIN9 in
regulation of mitotic genes in differentiated cells [9], [10]. In
somatic cells, LIN9 is part of the conserved DREAM multiprotein
complex that dynamically interacts with p130 and E2F4 early in
quiescent cells or with B-MYB in S phase and G2 [7], [8].
Figure 5. Validation of LIN9 target genes in ESCs. (A) & (C) Validation of microarray results by RT-qPCR. The expression of the indicated genes in
control transfected cells and cells transfected with pSUPER-LIN9 was compared. (B) Expression of Cyclin B1 in control transfected ESCs and ESCs
transfected with pSUPER-LIN9 was analyzed by immunoblotting. Tubulin was used as control for equal loading.
doi:10.1371/journal.pone.0062882.g005
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Consistent with the recent description of a DREAM-like complex
in embryonal carcinoma F9 cells [32], we find that LIN9 associates
with the other core-subunits of DREAM and with B-MYB, but not
with pocket proteins or E2F4 in ESCs. This suggests that LIN9
activates mitotic genes in ESCs in a complex together with
DREAM and B-MYB. The lack of binding of DREAM to pocket
proteins was expected, because pocket proteins are inactivated in
ESCs by hyperphosphorylation due to high levels of cyclin E-cdk2
activity [3]. Because DREAM does not interact with pocket
proteins in ESCs, these observations suggest that B-MYB/
DREAM acts directly in transcriptional activation of G2/M genes
as opposed to a possible indirect effect on inhibitory DREAM/
E2F4-p130 complexes.
While B-MYB has recently implicated in maintaining the
expression of pluripotency genes such as Oct4, Sox2 and Nanog in
ESCs [13], [14], in another study using a conditional allele of B-
MYB no change in expression of pluripotency genes after deletion
of B-MYB was detected [33]. Because the levels of pluripotency
genes are not changed after depletion of LIN9, our data do not
support a regulation of pluripotency genes by DREAM. Whether
B-MYB regulate these genes independently of DREAM remains to
be investigated.
We note that only a small proportion of the LIN9 bound genes
are differentially expressed in ESCs. It is possible that some of the
bound genes are enriched non-specifically e.g. by non-specific
amplification during the amplification step that is required before
hybridization to the promoter array. It is also possible that changes
in expression require a complete loss of LIN9 as opposed to the
partial depletion by RNAi. Finally these targets may be regulated
in different conditions, for example in another tissues or cell type.
The specific combination of other transcriptional regulators that
also contribute to the expression of these genes may determine
which genes are regulated by LIN9 in a given context.
Altogether our data suggest that the LIN9 subunit of the
DREAM complex is required for proliferation and genome
stability of ESCs through the regulation of key mitotic genes.
Materials and Methods
ESC Culture
Mouse ESCs (E14) [34] were cultured in DMEM (Life
Technologies) supplemented with 15% FCS (Life Technologies)
1000 u/ml LIF, non-essential amino acids, penicillin-streptomy-
cin, 0.1 mM ß-mercapto-ethanol, 1 mM Na-pyruvate (Life
Technologies) on gelatin-coated dishes. To generate an ESC line
in which LIN9 is metabolically labeled by biotin, the Lin9 cDNA
was cloned into the pEF-Flag-Bio plasmid [35] and the resistance
gene was exchanged with a neomycin resistance gene. pEF-FLAG-
Bio-Lin9 (neo) was transfected into ESCs that express the BirA
enzyme from the ROSA26 locus [18]. After selection with
neomycin (400 mg/ml), resistant clones were screened by immu-
noblotting and clones with equal levels of endogenous and
biotinylated LIN9 were identified.
Figure 6. Generation of a Biotag-LIN9 ESC line. (A) Scheme of N-terminal tagged LIN9 with the BirA recognition sequence. The biotin acceptor
lysine is indicated in red. BirA: E. coli biotin ligase (B) LIN9 was immunoprecipitated from ESCs stably expressing BirA alone or BirA and Biotag-LIN9.
LIN9 was detected by immunoblotting. The positions of endogenous and Biotag-LIN9 are indicated. (C) LIN9 was affinity purified with streptavidin-
coupled magnetic beads and detected by immunoblotting. (D) LIN9 was affinity purified with streptavidin-coupled magnetic beads. Bound proteins
were detected by immunoblotting.
doi:10.1371/journal.pone.0062882.g006
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Alkaline Phosphatase (AP) Activity
Alkaline Phosphatase (AP) activity was determined with the
Alkaline Phosphatase Detection Kit (Millipore).
In situ Hybridization
RNA in situ hybridization was performed as described
previously except that glass needles where used in instead of a
WISH chamber system [36].
Embryoid Body Formation
For embryoid body formation the hanging-drop-method was
used. To do so, an ESC suspension was prepared with 16104
cells/ml in LIF free ES medium. Drops of 20 ml (200 cells) were
placed on the lid of cell culture dishes and carefully placed on a
dish with 16PBS to prevent the cells from drying out. After 2 days
incubation, EBs were harvested and cultured in suspension on
dishes coated with 20 mg/ml poly(2-hydroxymethyl methacrylate)
(Sigma).
Figure 7. Identification of direct targets of LIN9 by ChIP-on-chip. (A) Functional categories of targets of LIN9 identified by ChIP-on-chip. LIN9
bound promoters were analyzed for enrichment of Gene Ontology terms. Shown are the top fifteen overrepresented GO terms according to the p-
value. For a complete list bound promoters and GO terms with a p-value of less than 0.05 see Supplemental Tables S4 and S5. (B) Mitotic genes are
direct targets of LIN9 in ESCs. Comparison of gene expression data and ChIP-on-chip data. Shown are genes that are downregulated after depletion
of LIN9 and that have a known function in mitosis. ‘‘!’’ indicates that binding of LIN9 to the promoter was detected by ChIP-on-chip. ‘‘2’’ indicates
that no binding was detected. (C) Binding of LIN9 to the promoters of randomly selected mitotic targets genes was confirmed by conventional ChIP.
doi:10.1371/journal.pone.0062882.g007
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Table 1. Direct target genes of LIN9 in ES cells as determined by microarray and ChIP-on-chip.
Gene name Direction Gene Description
2900011O08Rik down RIKEN cDNA 2900011O08 gene
3300002I08Rik up RIKEN cDNA 3300002I08 gene
4930547N16Rik down RIKEN cDNA 4930547N16 gene
A430089I19Rik up RIKEN cDNA A430089I19 gene
A530032D15Rik up Sp140 nuclear body protein
Acpp up acid phosphatase, prostate
Aspm down asp (abnormal spindle)-like, microcephaly associated (Drosophila)
Aurka down aurora kinase A
BC028528 up cDNA sequence BC028528
Bub3 down budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae)
Ccnb1 down cyclin B1
Cdc20 down cell division cycle 20 homolog (S. cerevisiae)
Cdca2 down cell division cycle associated 2
Cenpa down centromere protein A
Cenpe down centromere protein E
Cpne8 up copine VIII
Ctss up cathepsin S
Cyp2d26 down cytochrome P450, family 2, subfamily d, polypeptide 26
D17H6S56E-5 down DNA segment, Chr 17, human D6S56E 5
Depdc1b down DEP domain containing 1B
Dst up dystonin
Fbp2 up fructose bisphosphatase 2
Gas2l3 down growth arrest-specific 2 like 3
Gm9 down predicted gene 9
Grn down granulin
H1f0 down H1 histone family, member 0
Hist1h2bc down histone cluster 1, H2bc
Hmga2 up high mobility group AT-hook 2
Hmmr down hyaluronan mediated motility receptor (RHAMM)
Igfbp7 up insulin-like growth factor binding protein 7
Incenp down inner centromere protein
Inhbc up inhibin beta-C
Kif20a down kinesin family member 20A
Lmnb1 down lamin B1
Lrp4 up low density lipoprotein receptor-related protein 4
Ly6a down lymphocyte antigen 6 complex, locus A
Matn3 up matrilin 3
Msc down musculin
Oasl1 up 2’–5’ oligoadenylate synthetase-like 1
Pipox up pipecolic acid oxidase
Plk1 down polo-like kinase 1 (Drosophila)
Pnrc2 down proline-rich nuclear receptor coactivator 2
Polr3gl up polymerase (RNA) III (DNA directed) polypeptide G like
Prc1 down protein regulator of cytokinesis 1
Prom1 up prominin 1
Prr11 down proline rich 11
Psat1 down phosphoserine aminotransferase 1
Rlbp1 down retinaldehyde binding protein 1
Slc30a9 up solute carrier family 30 (zinc transporter), member 9
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Immunoprecipitation and Immunoblotting
Nuclear extracts were prepared as described before [37]. Briefly
cells were lysed with Nuclear Extraction Buffer A [20 mM
HEPES, 10 mM KCl, 1 mM EDTA, 0.1 mM Na3VO4, 0.2%
(v/v) Nonidet P40 (NP-40), 10% (v/v) glycerol, 1 mM DTT,
1 mM PMSF, protease inhibitor cocktail (Sigma)]. Nuclei were
collected by centrifugation and nuclear proteins were extracted
with Nuclear Extraction Buffer B [20 mM HEPES, 10 mM KCl,
1 mM EDTA, 0.1 mM Na3VO4, 350 mM NaCl, 20% (v/v)
glycerol, 1 mM DTT, 1 mM PMSF, protease inhibitor cocktail
(Sigma)]. Nuclear extracts were immunoprecipitated with LIN9
antibody (ab62329, Abcam) over night at 4uC, bound to Protein-G
Dynabeads (Life Technologies) and washed 5 times with TNN
[50 mM Tris (pH 7.5), 120 mM NaCl, 5 mM EDTA, 0.5%
NP40, 10 mM Na4P2O7, 2 mM Na3 VO4, 100 mM NaF, 10 mg/
mL phenylmethylsulfonyl fluoride, protease inhibitors (Sigma)].
Proteins were separated by SDS-PAGE, transferred to PVDF
membrane and detected by immunoblotting. The following
primary antibodies were used: p107 (sc-318), p130 (sc-317),
CCNB1 (sc-245) (all from Santa Cruz) and Tubulin (B-5-1,
Sigma). The LIN9, LIN54, and LIN37 antibodies have been
described before [7], The MYBL2 antibody (LX015.1) has also
been described [38].
RNAi
pSUPER-puro Lin9 was generated by inserting an oligonucle-
otide with the following target sequence specific for mouse Lin9
into pSUPER-puro: 5’ GCUACUUACAGAGUAACUUUC 3’
[32]. ESCs were transfected with Lipofectamine 2000 (Invitrogen)
and selected with 1 mg/ml puromycin (Invivogen).
Chromatin-Immunoprecipitation (ChIP) and ChIP-on-chip
For ChIP, 56107 cells were cross-linked with 1% formaldehyde
for 10 min at room temperature. Cross-linking was terminated by
125 mM glycine and cells were washed with cold phosphate-
buffered saline (PBS) containing 10 mg/mL phenylmethylsulfonyl
fluoride, collected by centrifugation and washed again. The cell
pellet was resuspended in SDS ChIP buffer [0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris-Cl pH 8.1, 150 mM
NaCl, and protease inhibitor cocktail (Sigma)]. DNA was
fragmented to an average size 0.5–1 kb with the Bioruptor
sonificator from Diagenode. Chromatin was precipitated by
addition of BSA and ssDNA pre-blocked Streptavidin M250
Dynabeads (Life Technologies) and incubated for 5 hours.
Precipitated chromatin was successively washed with buffer I
(2% SDS), buffer II [0.1% Deoxycholate, 1% Triton X-100,
1 mM EDTA, 50 mM HEPES pH 7.5, 500 mM NaCl], buffer III
[250 mM LiCl, 0.5% NP-40, 0.5% Deoxycholate, 1 mM EDTA,
10 mM Tris-Cl pH 8.1] and TE buffer [10 mM Tris-Cl pH 7.5,
1 mM EDTA]. SDS elution buffer [50 mM Tris-Cl pH 8.0, 1%
SDS, 10 mM EDTA] was added and incubated at 65uC overnight
to reverse the crosslink. The sample was treated with 1 ml RNase A
[10 mg/ml] and 2 ml Proteinase K [10 mg/ml]. DNA was
purified with the Qiagen PCR Purification Kit according to the
manufacture’s protocol and resuspended in 25 ml H2O. Enrich-
ment of DNA was analyzed by quantitative real-time PCR. Primer
sequences are listed below.
For ChIP-on-chip, crosslinked chromatin was prepared from
26108 Bio-Lin9 cells and precipitated with streptavidin-coupled
Dynabeads (Life Technologies) as described above. The crosslink
was reversed, the DNA eluted and purified. Precipitated samples
and input DNA were amplified using the WGA2 kit (Sigma). 4 mg
amplified DNA was labelled with Cy5 and Cy3 and hybridized to
a MM8 385 k NimbleGen Mouse ChIP 385 k RefSeq promoter
array containing oligonucleotide probes that cover the region 22
to +0.5 kb relative to the transcriptional start sites for 19,489
annotated transcripts. Probes consisted of 50- to 75-mers at
approximately 100 bp spacing. DNA labeling, hybridization,
detection and data analysis were performed using the services of
Imagenes (Berlin). Signal intensity data were extracted from the
scanned images of each array using NimbleScan data extraction
software. Log2 ratio of experimental and input signals was then
computed and scaled and peak data files were generated (.gff) by
identifying four or more consecutive probes, whose signals are
above a cutoff value (a percentage of the hypothetical maximum
(mean +6 standard deviation) using a 500 bp sliding window. The
probability of false discovery is calculated by randomizing the data
20 times and each peak is given a false discovery rate (FDR), where
the lower the FDR score, the higher the probability that peak
represents a true binding site. Enriched peaks were visualized
using SignalMap. Promoters with a FDR ,0.1 and a peak score
.1 were considered positive LIN9 targets.
Microarray
Using the two color Quick-Amp Labeling Kit (Agilent) 0.1 mg of
total RNA was used for cDNA synthesis, mRNA amplification and
labeling according to manufacturer’s instructions. Transcriptional
profiling was done on an 44 K oligo array (Agilent) and analyzed
as described before [39]. Expression data and gene annotations
Table 1. Cont.
Gene name Direction Gene Description
Snap91 up synaptosomal-associated protein 91
Socs2 up suppressor of cytokine signaling 2
Speer4d up spermatogenesis associated glutamate (E)-rich protein 4d
Spnb1 up spectrin beta 1
Syt10 down synaptotagmin X
Tax1bp1 up Tax1 (human T cell leukemia virus type I) binding protein 1
Tpm1 up tropomyosin 1, alpha
Ube2c down ubiquitin-conjugating enzyme E2C
Zfp28 down zinc finger protein 28
Zfp521 up zinc finger protein 521
doi:10.1371/journal.pone.0062882.t001
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were stored in Array Express (http://www.ebi.ac.uk/
arrayexpress/) (accession: E-MTAB-1490), which complies with
MIAME (minimal information about a microarray experiment)
guidelines.
Real-time Quantitative PCR
Total RNA was isolated with Trifast (Peqlab), reverse
transcribed with 0.5 units M-MLV-RT Transcriptase (Thermo
Scientific) and analyzed with quantitative real-time PCR with
SYBR Green reagents from Thermo Scientific using the Mx3000
(Agilent technologies) detection system. Expression differences
were calculated relative to GAPDH as described before [7].
FACS Analysis
For FACS analysis cells were stained with propidium iodide and
analyzed on a Beckman Coulter FC500.
Primer Sequences
Primers for RT-qPCR:
b-actin
59-CTAAGGCCAACCGTGAAAAG-39 forward
59-ACCAGAGGCATACAGGGACA-39 reverse
Lin9
59-TTGGGACTCACACCATTCCT-39 forward
59-GAAGGCCGCTGTTTTTGTC-39 reverse
Ccnb1
59-CGCTGAAAATTCTTGACAACG-39 forward
59-TCTTAGCCAGGTGCTGCATA-39 reverse
Aspm
59-GATGGAGGCCGAGAGAGG-39 forward
59-CAGCTTCCACTTTGGATAAGTATTTC-39 reverse
Nusap1
59-TCTAAACTTGGGAACAATAAAAGGA-39 forward
59-TGGATTCCATTTTCTTAAAACGA-39 reverse
Aurka
59-GGGACATGGCTGTTGAGG-39 forward
59-GTTTTCTTTACATCTGTCCATGTCA-39 reverse
Oct4
59-GTTGGAGAAGGTGGAACCAA-39 forward
59-CTCCTTCTGCAGGGCTTTC-39 reverse
Flk1
59-CAGTGGTACTGGCAGCTAGAAG-39 forward
59-ACAAGCATACGGGCTTGTTT-39 reverse
Vax2
59-ACTGAGTTGGCCCGACAG-39 forward
59-CCCGCTTCTCCAGGTCTC-39 reverse
NeuroD1
59-CGCAGAAGGCAAGGTGTC-39 forward
59-TTTGGTCATGTTTCCACTTCC-39 reverse
Gm11487
59-AGCTCAGGAGACAAAATGCAG-39 forward
59-CTGAGGAACTTTGGCCTTCTT-39 reverse
AFP
59-CATGCTGCAAAGCTGACAA-39 forward
59-CTTTGCAATGGATGCTCTCTT-39 reverse
Pcdh8
59-GAAGTTCAGTGGGAAAGACAGC-39 forward
59-GTACACGCCCACAGTCCAC-39 reverse
Pdgfra
59-GTCGTTGACCTGCAGTGGA-39 forward
59-GTCGTTGACCTGCAGTGGA-39 reverse
Stmn3
59-CTGAGGAGCGGAGGAAGA-39 forward
59-CCTCCCGTTCATGCTCAC-39 reverse
Id4
59-AGGGTGACAGCATTCTCTGC-39 forward
59-CCGGTGGCTTGTTTCTCTTA-39 reverse
Primers for ChIP:
Kif20a
59-CAGACAGTCTTCGGGTGAGTG-39 forward
59-CTTCTACGGACGCGCAAG-39 reverse
Hmmr
59-TCGCCTGAATTCAAATTTACC-39 forward
59-CAGGATTGGCCAGATAGGTT-39 reverse
Aurka
59-AGAAGGCTGCGGGAAGAG-39 forward
59-GTCTGTGGATGAACGGGAGT-39 reverse
Aspm
59-GCTGTAGCGAGGAGGTTCC-39 forward
59-TTTTGCTCGGTTCAAATATCG-39 reverse
Sox2
Supporting Information
Figure S1 Embryoid bodies formed in control cells and
LIN9-depleted cells. Scale bar: 100 mM. See also Figure 2D.
(PDF)
Table S1 LIN9 regulated genes in ESCs as determined
by microarray analysis.
(XLS)
Table S2 GO term analysis of genes downregulated
after depletion of LIN9.
(XLSX)
Table S3 GO term analysis of genes upregulated after
depletion of LIN9.
(XLSX)
Table S4 Genes bound by LIN9 based on CHIP-on-chip
analysis.
(XLSX)
Table S5 GO term analysis of genes bound by LIN9.
(XLSX)
Acknowledgments
We thank all members of the laboratory for their suggestions and critical
reading of the manuscript. We would like to thank Dies Meier for
providing the BirA ESCs, Roger Watson for pSUPER-LIN9 and
monoclonal B-MYB antibody and Alan Cantor and John Strouboulis for
biotin-tagging constructs.
Author Contributions
Conceived and designed the experiments: SG. Performed the experiments:
JE NR MK FI. Analyzed the data: FF. Wrote the paper: SG JE.
References
1. Young RA (2011) Control of the embryonic stem cell state. Cell 144: 940–954.
doi:10.1016/j.cell.2011.01.032.
2. White J, Stead E, Faast R, Conn S, Cartwright P, et al. (2005) Developmental
activation of the Rb-E2F pathway and establishment of cell cycle-regulated
cyclin-dependent kinase activity during embryonic stem cell differentiation. Mol
Biol Cell 16: 2018–2027. doi:10.1091/mbc.E04–12–1056.
3. Stead E, White J, Faast R, Conn S, Goldstone S, et al. (2002) Pluripotent cell
division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities.
Oncogene 21: 8320–8333. doi:10.1038/sj.onc.1206015.
Role of LIN9 in Embryonic Stem Cells
PLOS ONE | www.plosone.org 12 May 2013 | Volume 8 | Issue 5 | e62882
4. Li VC, Ballabeni A, Kirschner MW (2012) Gap 1 phase length and mouse
embryonic stem cell self-renewal. Proc Natl Acad Sci USA 109: 12550–12555.
doi:10.1073/pnas.1206740109.
5. Korenjak M, Taylor-Harding B, Binne´ UK, Satterlee JS, Stevaux O, et al.
(2004) Native E2F/RBF complexes contain Myb-interacting proteins and
repress transcription of developmentally controlled E2F target genes. Cell 119:
181–193. doi:10.1016/j.cell.2004.09.034.
6. Lewis PW, Beall EL, Fleischer TC, Georlette D, Link AJ, et al. (2004)
Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor
complex. Genes Dev 18: 2929–2940. doi:10.1101/gad.1255204.
7. Schmit F, Korenjak M, Mannefeld M, Schmitt K, Franke C, et al. (2007) LINC,
a human complex that is related to pRB-containing complexes in invertebrates
regulates the expression of G2/M genes. Cell Cycle 6: 1903–1913.
8. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, et al. (2007)
Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex
represses human cell cycle-dependent genes in quiescence. Mol Cell 26: 539–
551. doi:10.1016/j.molcel.2007.04.015.
9. Osterloh L, Eyss von B, Schmit F, Rein L, Hu¨bner D, et al. (2007) The human
synMuv-like protein LIN-9 is required for transcription of G2/M genes and for
entry into mitosis. EMBO J 26: 144–157. doi:10.1038/sj.emboj.7601478.
10. Pilkinton M, Sandoval R, Song J, Ness SA, Colamonici OR (2007) Mip/LIN-9
regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and
CDK1. J Biol Chem 282: 168–175. doi:10.1074/jbc.M609924200.
11. Reichert N, Wurster S, Ulrich T, Schmitt K, Hauser S, et al. (2010) Lin9, a
subunit of the mammalian DREAM complex, is essential for embryonic
development, for survival of adult mice, and for tumor suppression. Mol Cell
Biol 30: 2896–2908. doi:10.1128/MCB.00028-10.
12. Tanaka Y, Patestos NP, Maekawa T, Ishii S (1999) B-myb is required for inner
cell mass formation at an early stage of development. J Biol Chem 274: 28067–
28070.
13. Tarasov KV, Tarasova YS, Tam WL, Riordon DR, Elliott ST, et al. (2008) B-
MYB is essential for normal cell cycle progression and chromosomal stability of
embryonic stem cells. PLoS ONE 3: e2478. doi:10.1371/journal.pone.0002478.
14. Zhan M, Riordon DR, Yan B, Tarasova YS, Bruweleit S, et al. (2012) The B-
MYB Transcriptional Network Guides Cell Cycle Progression and Fate
Decisions to Sustain Self-Renewal and the Identity of Pluripotent Stem Cells.
PLoS ONE 7: e42350. doi:10.1371/journal.pone.0042350.
15. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. (1998)
Formation of pluripotent stem cells in the mammalian embryo depends on the
POU transcription factor Oct4. Cell 95: 379–391.
16. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells
from mouse embryos. Nature 292: 154–156.
17. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI (1995) Embryonic stem
cells express neuronal properties in vitro. Dev Biol 168: 342–357. doi:10.1006/
dbio.1995.1085.
18. Driegen S, Ferreira R, van Zon A, Strouboulis J, Jaegle M, et al. (2005) A
generic tool for biotinylation of tagged proteins in transgenic mice. Transgenic
Res 14: 477–482.
19. Snow MH, Bennett D (1978) Gastrulation in the mouse: assessment of cell
populations in the epiblast of tw18/tw18 embryos. J Embryol Exp Morphol 47:
39–52.
20. Brandeis M, Rosewell I, Carrington M, Crompton T, Jacobs MA, et al. (1998)
Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null
mice die in utero. Proc Natl Acad Sci USA 95: 4344–4349.
21. Lu L-Y, Wood JL, Minter-Dykhouse K, Ye L, Saunders TL, et al. (2008) Polo-
like kinase 1 is essential for early embryonic development and tumor
suppression. Mol Cell Biol 28: 6870–6876. doi:10.1128/MCB.00392-08.
22. Kalitsis P, Earle E, Fowler KJ, Choo KH (2000) Bub3 gene disruption in mice
reveals essential mitotic spindle checkpoint function during early embryogenesis.
Genes Dev 14: 2277–2282.
23. Weaver BAA, Bonday ZQ, Putkey FR, Kops GJPL, Silk AD, et al. (2003)
Centromere-associated protein-E is essential for the mammalian mitotic
checkpoint to prevent aneuploidy due to single chromosome loss. J Cell Biol
162: 551–563. doi:10.1083/jcb.200303167.
24. Cutts SM, Fowler KJ, Kile BT, Hii LL, O’Dowd RA, et al. (1999) Defective
chromosome segregation, microtubule bundling and nuclear bridging in inner
centromere protein gene (Incenp)-disrupted mice. Hum Mol Genet 8: 1145–
1155.
25. Howman EV, Fowler KJ, Newson AJ, Redward S, MacDonald AC, et al. (2000)
Early disruption of centromeric chromatin organization in centromere protein A
(Cenpa) null mice. Proc Natl Acad Sci USA 97: 1148–1153.
26. Minato Y, Tashiro E, Kanai M, Nihei Y, Kodama Y, et al. (2007)
Transcriptional regulation of a new variant of human platelet-derived growth
factor receptor alpha transcript by E2F-1. Gene 403: 89–97. doi:10.1016/
j.gene.2007.08.011.
27. Singh AM, Dalton S (2009) The cell cycle and Myc intersect with mechanisms
that regulate pluripotency and reprogramming. Cell Stem Cell 5: 141–149.
doi:10.1016/j.stem.2009.07.003.
28. Orford KW, Scadden DT (2008) Deconstructing stem cell self-renewal: genetic
insights into cell-cycle regulation. Nat Rev Genet 9: 115–128. doi:10.1038/
nrg2269.
29. He S, Nakada D, Morrison SJ (2009) Mechanisms of stem cell self-renewal.
Annu Rev Cell Dev Biol 25: 377–406. doi:10.1146/annurev.cell-
bio.042308.113248.
30. Lange C, Calegari F (2010) Cdks and cyclins link G1 length and differentiation
of embryonic, neural and hematopoietic stem cells. Cell Cycle 9: 1893–1900.
31. White J, Dalton S (2005) Cell cycle control of embryonic stem cells. Stem Cell
Rev 1: 131–138. doi:10.1385/SCR:1:2:131.
32. Knight AS, Notaridou M, Watson RJ (2009) A Lin-9 complex is recruited by B-
Myb to activate transcription of G2/M genes in undifferentiated embryonal
carcinoma cells. Oncogene 28: 1737–1747. doi:10.1038/onc.2009.22.
33. Lorvellec M, Dumon S, Maya-Mendoza A, Jackson D, Frampton J, et al. (2010)
B-Myb is critical for proper DNA duplication during an unperturbed S phase in
mouse embryonic stem cells. Stem cells (Dayton, Ohio) 28: 1751–1759.
doi:10.1002/stem.496.
34. Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient
(Lesch-Nyhan) mouse embryos derived from germline colonization by cultured
cells. Nature 326: 292–295. doi:10.1038/326292a0.
35. Woo AJ, Moran TB, Schindler YL, Choe S-K, Langer NB, et al. (2008)
Identification of ZBP-89 as a novel GATA-1-associated transcription factor
involved in megakaryocytic and erythroid development. Mol Cell Biol 28: 2675–
2689. doi:10.1128/MCB.01945-07.
36. Yoshikawa T, Piao Y, Zhong J, Matoba R, Carter MG, et al. (2006) High-
throughput screen for genes predominantly expressed in the ICM of mouse
blastocysts by whole mount in situ hybridization. Gene Expr Patterns 6: 213–
224. doi:10.1016/j.modgep.2005.06.003.
37. Kim J, Cantor AB, Orkin SH, Wang J (2009) Use of in vivo biotinylation to
study protein-protein and protein-DNA interactions in mouse embryonic stem
cells. Nat Protoc 4: 506–517. doi:10.1038/nprot.2009.23.
38. Tavner F, Frampton J, Watson RJ (2007) Targeting an E2F site in the mouse
genome prevents promoter silencing in quiescent and post-mitotic cells.
Oncogene 26: 2727–2735. doi:10.1038/sj.onc.1210087.
39. Kleinschmidt MA, Streubel G, Samans B, Krause M, Bauer U-M (2008) The
protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene
regulation. Nucleic Acids Res 36: 3202–3213. doi:10.1093/nar/gkn166.
Role of LIN9 in Embryonic Stem Cells
PLOS ONE | www.plosone.org 13 May 2013 | Volume 8 | Issue 5 | e62882
